HEALTHSTAT NEWS
STAT+: Want high-quality generic drugs? One expert has ideas on how consumers can trust their supply
Generic drugs, which make up 90% of U.S. prescriptions, face quality issues leading to shortages, with over 60% of shortages due to quality concerns. Kevin Schulman, a Stanford professor, proposes FDA-encouraged independent lab testing to improve trust, citing Valisure's findings of impurities in medicines.
Mentioned
Related Signal
Adjacent reporting
- India’s Generic Copies Dent Eli Lilly’s Sales
- STAT+: White House taps Amazon, GoodRx, and Mark Cuban to bolster TrumpRx
- Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
- Canada and India now have generic Wegovy. Here’s why the U.S. doesn’t.
- Loophole in patent law brings ‘miracle drug’ to patients who can’t afford it
- STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much more